Actively Recruiting
Prevention of Hernia After Loop Ileostomy Reversal
Led by Karolinska Institutet · Updated on 2025-08-19
208
Participants Needed
4
Research Sites
617 weeks
Total Duration
On this page
Sponsors
K
Karolinska Institutet
Lead Sponsor
S
Stockholm South General Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
PHaLIR is a prospective, double-blinded randomized study in which patients planned for stoma reversal after rectal cancer surgery are randomized between retro muscular mesh Ultrapro Advanced or standard treatment without mesh.
CONDITIONS
Official Title
Prevention of Hernia After Loop Ileostomy Reversal
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients operated for low anterior resection for rectal cancer with a diverting loop ileostomy and planned for stoma reversal
You will not qualify if you...
- Language barrier or cognitive disability
- Recurrent cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
Södertälje Hospital
Södertälje, Sweden
Actively Recruiting
2
Stockholm South General Hospital
Stockholm, Sweden, 11883
Actively Recruiting
3
Ersta Hospital
Stockholm, Sweden
Actively Recruiting
4
Västmanland Hospital
Västerås, Sweden
Actively Recruiting
Research Team
Å
Åsa Hallqvist Everhov, MD, PhD
CONTACT
J
Jonas Nygren, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here